Movement · Resistance Training · Longevity · Neurological Health
A 2026 Harvard study following 147,374 health professionals over three decades found that 90–119 minutes of resistance training per week reduces all-cause mortality by 13% and cardiovascular mortality by 19%. The number that made fewer headlines — and deserves more — is the 27% reduction in neurological disease mortality. That figure, in isolation, is larger than the protective effect of any pharmacological intervention currently available for neurological disease prevention in healthy adults.
In June 2026, Yiwen Zhang and colleagues at Harvard T.H. Chan School of Public Health published the results of a 30-year analysis of 147,374 adults — nurses, physicians, and health professionals — tracked across three landmark cohort studies. Their question: how does the weekly dose of resistance training relate to mortality risk, and at what point do the returns stop?
The dose-response finding was specific: benefit rises steeply from zero to 90 minutes per week, then flattens. There is no measurable additional longevity benefit from doing more than 120 minutes per week of resistance training. The threshold that produces the full biological effect is 90 minutes. Getting there is the intervention. Maintaining it is the intervention. Above it, you are training for other reasons — performance, body composition, enjoyment — but not adding years to your life.
This overturns a cultural assumption that the gym culture has embedded deeply: that more effort produces proportionally better outcomes. For longevity, it does not. The dose-response curve is front-loaded. Three 30-minute sessions per week captures virtually the full biological benefit. That is an accessible target for almost anyone, framed correctly.
The 13% reduction in all-cause mortality and the 19% reduction in cardiovascular deaths generated the headlines. They are impressive. But the 27% reduction in neurological disease mortality — deaths from Alzheimer's disease, Parkinson's disease, and related neurodegenerative conditions — is the finding that should have led every coverage of this study.
There is currently no pharmacological intervention that reduces neurological disease mortality in healthy adults by 27%. Not donepezil, not memantine, not any of the amyloid-targeting antibodies that have generated such controversy in recent Alzheimer's drug approvals. None of them, used in healthy people as prevention, produces a protective effect of this magnitude.
Resistance training does. At 90 minutes per week. At zero pharmaceutical cost. With additional benefits for cardiovascular health, metabolic function, bone density, insulin sensitivity, hormonal regulation, and every cause of death measured in the study.
27% lower neurological disease mortality from 90 minutes of lifting per week is a clinical finding that should change how we discuss dementia risk and prevention. The pharmacological research gets the headlines. The resistance training data gets the lifestyle section.
The most striking single finding in the study is not the resistance-only effect. It is what happens when resistance training is combined with aerobic exercise within recommended ranges: up to 45% lower all-cause mortality compared to those who did neither.
Neither modality alone reaches this figure. Aerobic exercise alone produces significant benefit. Resistance training alone produces significant benefit. But combining them produces a protective effect that exceeds what either achieves independently — and the magnitude of that combination effect suggests the two modalities are working through distinct biological mechanisms that together produce something greater than the sum of their parts.
The cardiovascular benefit of resistance training is reasonably well understood: improved insulin sensitivity reduces the metabolic CVD risk load, increased lean muscle mass improves glucose disposal, and the vascular adaptations to resistance exercise (improved endothelial function, reduced arterial stiffness) directly address cardiovascular risk factors.
The neurological benefit operates through different pathways — which is the mechanistic reason why combining aerobic and resistance exercise produces effects neither achieves independently, and why the neurological protection appears to be specifically associated with resistance training rather than simply with total exercise volume.
The flattening of longevity benefit above 120 minutes per week carries a practical implication that is clinically important and runs counter to most gym culture: you do not need to train more than 90 minutes per week to capture the full mortality benefit. Going from 90 minutes to four hours of lifting per week does not add further longevity benefit over the threshold dose.
This matters in two directions. For people who currently do no resistance training, the gap between zero and 90 minutes is enormous in mortality terms — larger than any further increase above 90 minutes. The intervention is getting to 90 minutes. Not optimising beyond it.
For people already training significantly more than 90 minutes, the data suggests there are good reasons to train at that volume — performance goals, body composition, enjoyment, and sport-specific requirements — but adding longevity years is not among the primary returns above the threshold.
The accessible frame is this: three sessions of 30 minutes per week captures essentially the full longevity benefit that resistance training can provide. That is not a heroic commitment. It is a sustainable weekly practice that, compounded over decades, produces a 27% reduction in neurological disease mortality and a 45% reduction in all-cause mortality when combined with adequate aerobic activity.
Resistance training is one of the few lifestyle interventions with demonstrated effects on DunedinPACE — the DNA methylation clock that measures the pace of biological ageing. Individuals who maintain consistent resistance training have measurably slower biological ageing by this metric. This is not a theoretical claim — it is observable in the epigenetic data.
The mechanism connects directly to what the longevity study is measuring: reduced all-cause mortality is, at the biological level, slowed ageing. The same processes — improved insulin sensitivity, reduced inflammation, preserved muscle mass, maintained neuroplasticity — that reduce mortality risk at the population level produce measurable changes in biological age clocks at the individual level.
For someone using TruDiagnostic TruAge testing to measure biological age, resistance training is the single most evidence-supported intervention for actually moving the DunedinPACE figure in the right direction over 12 months of measurement.
I have a boxing and athletics coaching background going back to age 18. The movement competence, the body composition, the metabolic resilience, the stress capacity, the injury resistance that come from consistent, progressive physical training — these are not theoretical. I have observed them in clients across 37 years of clinical practice, in populations ranging from elite athletes to sedentary office workers with multi-system dysfunction.
The consistent observation is that people who maintain regular resistance training as a background to their health — not obsessively, not competitively, but consistently — present with fundamentally different clinical pictures from age-matched sedentary populations. Better insulin sensitivity, better cortisol regulation, better inflammatory markers, better bone density, better cognitive function, better sleep quality. Not because resistance training solved every problem, but because the underlying metabolic and neurological substrate is maintained at a level that makes everything else function better.
The Harvard study has now put numbers on what clinical experience suggested. 27% lower neurological disease mortality. 45% combined mortality reduction. From a 90-minute weekly commitment that is available to almost everyone.
That is not a lifestyle recommendation. That is a clinical prescription.
DunedinPACE measures your current pace of ageing — sensitive to lifestyle intervention and retestable at 12 months to measure change. Combined with resistance training, it gives you an objective measure of whether the work is shifting the biology.
DH Longevity Investigation — £750